NIAMS is offering the Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases grant to support innovative research projects focusing on exploring unusual observations, testing imaginative hypotheses, and developing ground-breaking paradigms related to musculoskeletal diseases. This grant encourages projects considered too risky or unconventional for other NIH mechanisms and aims to fund translational studies focused on understanding disease mechanisms or developing diagnostic, therapeutic, or preventive interventions. The RISK grant does not support clinical trials and is open for applications until January 9, 2020.
Opportunity ID: 307314
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-AR-19-013 |
Funding Opportunity Title: | Research Innovations for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.846 — Arthritis, Musculoskeletal and Skin Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jul 20, 2018 |
Last Updated Date: | – |
Original Closing Date for Applications: | Jan 09, 2020 |
Current Closing Date for Applications: | Jan 09, 2020 |
Archive Date: | Feb 14, 2020 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Special district governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses City or township governments Independent school districts State governments Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) County governments Private institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The NIAMS Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33) initiative focuses on innovative research within the NIAMS mission by encouraging applicants to pursue unusual observations, test imaginative hypotheses, investigate creative concepts, and build ground-breaking paradigms, all of which deviate significantly from the current prevailing theories or practice. This FOA is particularly designed to encourage the submission of projects that are considered too risky, premature, controversial, or unconventional for other NIH mechanisms. This FOA intends to support disease-focused translational studies. We invite research studies aimed at understanding the mechanisms of diseases or conditions relevant to the NIAMS mission, as well as studies aimed at developing or testing diagnostics, therapeutic agents, or preventive interventions up to, but not including, first in human studies. The RISK R61/R33 FOAs are not intended to support clinical trials. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-19-013.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | FORMS-E | PKG00243889 | Mar 09, 2019 | Jan 09, 2020 | View |
Package 1
Mandatory forms
307314 RR_SF424_2_0-2.0.pdf
307314 PHS398_CoverPageSupplement_4_0-4.0.pdf
307314 RR_OtherProjectInfo_1_4-1.4.pdf
307314 PerformanceSite_2_0-2.0.pdf
307314 RR_KeyPersonExpanded_2_0-2.0.pdf
307314 RR_Budget_1_4-1.4.pdf
307314 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
307314 RR_SubawardBudget30_1_4-1.4.pdf
307314 PHS_AssignmentRequestForm_2_0-2.0.pdf